Literature DB >> 22209149

First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.

Heinz Deutschmann1, Gerhard Kametriser, Philipp Steininger, Philipp Scherer, Helmut Schöller, Christoph Gaisberger, Michaela Mooslechner, Bernhard Mitterlechner, Harald Weichenberger, Gert Fastner, Karl Wurstbauer, Stephan Jeschke, Rosemarie Forstner, Felix Sedlmayer.   

Abstract

PURPOSE: We developed and evaluated a correction strategy for prostate rotations using direct adaptation of segments in intensity-modulated radiotherapy (IMRT). METHOD AND MATERIALS: Implanted fiducials (four gold markers) were used to determine interfractional translations, rotations, and dilations of the prostate. We used hybrid imaging: The markers were automatically detected in two pretreatment planar X-ray projections; their actual position in three-dimensional space was reconstructed from these images at first. The structure set comprising prostate, seminal vesicles, and adjacent rectum wall was transformed accordingly in 6 degrees of freedom. Shapes of IMRT segments were geometrically adapted in a class solution forward-planning approach, derived within seconds on-site and treated immediately. Intrafractional movements were followed in MV electronic portal images captured on the fly.
RESULTS: In 31 of 39 patients, for 833 of 1013 fractions (supine, flat couch, knee support, comfortably full bladder, empty rectum, no intraprostatic marker migrations >2 mm of more than one marker), the online aperture adaptation allowed safe reduction of margins clinical target volume-planning target volume (prostate) down to 5 mm when only interfractional corrections were applied: Dominant L-R rotations were found to be 5.3° (mean of means), standard deviation of means ±4.9°, maximum at 30.7°. Three-dimensional vector translations relative to skin markings were 9.3 ± 4.4 mm (maximum, 23.6 mm). Intrafractional movements in 7.7 ± 1.5 min (maximum, 15.1 min) between kV imaging and last beam's electronic portal images showed further L-R rotations of 2.5° ± 2.3° (maximum, 26.9°), and three-dimensional vector translations of 3.0 ±3.7 mm (maximum, 10.2 mm). Addressing intrafractional errors could further reduce margins to 3 mm.
CONCLUSION: We demonstrated the clinical feasibility of an online adaptive image-guided, intensity-modulated prostate protocol on a standard linear accelerator to correct 6 degrees of freedom of internal organ motion, allowing safe and straightforward implementation of margin reduction and dose escalation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209149     DOI: 10.1016/j.ijrobp.2011.10.009

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  21 in total

Review 1.  Review of Real-Time 3-Dimensional Image Guided Radiation Therapy on Standard-Equipped Cancer Radiation Therapy Systems: Are We at the Tipping Point for the Era of Real-Time Radiation Therapy?

Authors:  Paul J Keall; Doan Trang Nguyen; Ricky O'Brien; Pengpeng Zhang; Laura Happersett; Jenny Bertholet; Per R Poulsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-04-14       Impact factor: 7.038

2.  The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients.

Authors:  O C Guler; B Engels; C Onal; H Everaert; R Van den Begin; T Gevaert; M de Ridder
Journal:  Clin Transl Oncol       Date:  2017-08-09       Impact factor: 3.405

3.  The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans.

Authors:  Katja M Langen; Bhavin Chauhan; Jeffrey V Siebers; Joseph Moore; Patrick A Kupelian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-06       Impact factor: 7.038

4.  Variation in patient position and impact on carbon-ion scanning beam distribution during prostate treatment.

Authors:  S Mori; T Inaniwa; K Miki; K Tanimoto; M Tajiri; D Kuroiwa; M Nakao; Y Shiraishi; K Shibayama; H Tsuji
Journal:  Br J Radiol       Date:  2015-05-07       Impact factor: 3.039

Review 5.  Adaptive proton therapy.

Authors:  Harald Paganetti; Pablo Botas; Gregory C Sharp; Brian Winey
Journal:  Phys Med Biol       Date:  2021-11-15       Impact factor: 3.609

Review 6.  Hypofractionated radiotherapy for localized prostate cancer.

Authors:  Stefan Höcht; Daniel M Aebersold; Clemens Albrecht; Dirk Böhmer; Michael Flentje; Ute Ganswindt; Tobias Hölscher; Thomas Martin; Felix Sedlmayer; Frederik Wenz; Daniel Zips; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2016-09-14       Impact factor: 3.621

7.  Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins. Different alignment techniques in 3D conformal prostate cancer radiotherapy.

Authors:  T Langsenlehner; C Döller; P Winkler; G Gallé; K S Kapp
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

Review 8.  Target margins in radiotherapy of prostate cancer.

Authors:  Slav Yartsev; Glenn Bauman
Journal:  Br J Radiol       Date:  2016-07-20       Impact factor: 3.039

9.  PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.

Authors:  Christoph Oehler; Stephanie Lang; Peter Dimmerling; Christian Bolesch; Stephan Kloeck; Alessandra Tini; Christoph Glanzmann; Yousef Najafi; Gabriela Studer; Daniel R Zwahlen
Journal:  Radiat Oncol       Date:  2014-11-11       Impact factor: 3.481

10.  Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.

Authors:  Vanessa Da Silva Mendes; Lukas Nierer; Minglun Li; Stefanie Corradini; Michael Reiner; Florian Kamp; Maximilian Niyazi; Christopher Kurz; Guillaume Landry; Claus Belka
Journal:  Radiat Oncol       Date:  2021-07-21       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.